We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+0.6%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$19.3B
AUM Growth
-$1.09B
Cap. Flow
-$60.5M
Cap. Flow %
-0.31%
Top 10 Hldgs %
26.11%
Holding
463
New
43
Increased
126
Reduced
234
Closed
29

Top Buys

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$154M
2
CFLT
Confluent
CFLT
+$146M
3
TOST icon
Toast
TOST
+$139M
4
SNOW icon
Snowflake
SNOW
+$66.8M
5
CURV icon
Torrid Holdings
CURV
+$66.6M

Sector Composition

Rank Sector Weight
1 Technology 34.48%
2 Consumer Discretionary 18.43%
3 Healthcare 18.09%
4 Communication Services 11.29%
5 Miscellaneous 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTS icon
301
AST SpaceMobile
ASTS
$17.6B
$826K ﹤0.01%
76,367
+177
+0.2% +$1.99K
SMAR
302
DELISTED
Smartsheet Inc.
SMAR
$801K ﹤0.01%
11,646
-37
-0.3% -$2.72K
SGHT icon
303
Sight Sciences
SGHT
$445M
$770K ﹤0.01%
+33,903
New +$1.11M
RNAM
304
DELISTED
Avidity Biosciences
RNAM
$766K ﹤0.01%
31,109
+16,539
+114% +$359K
GH icon
305
Guardant Health
GH
$22.8B
$750K ﹤0.01%
6,002
-147
-2% -$17.5K
CCC
306
CCC Intelligent Solutions
CCC
$3.98B
$745K ﹤0.01%
70,878
-19,710
-22% -$204K
SRPT icon
307
Sarepta Therapeutics
SRPT
$2.17B
$725K ﹤0.01%
7,841
-206
-3% -$15.9K
GDYN icon
308
Grid Dynamics Holdings
GDYN
$659M
$705K ﹤0.01%
+24,129
New +$590K
TSHA icon
309
Taysha Gene Therapies
TSHA
$1.63B
$700K ﹤0.01%
37,578
-62
-0.2% -$1.18K
OPEN icon
310
Opendoor
OPEN
$2.59B
$659K ﹤0.01%
+33,171
New +$536K
YOU icon
311
Clear Secure
YOU
$4.31B
$632K ﹤0.01%
15,397
+133
+0.9% +$6.22K
DAVA icon
312
Endava
DAVA
$156M
$630K ﹤0.01%
+4,634
New +$598K
DKNG icon
313
DraftKings
DKNG
$12.3B
$604K ﹤0.01%
12,545
-18,793
-60% -$996K
ATEX icon
314
Anterix
ATEX
$1.5B
$567K ﹤0.01%
9,339
-4
-0% -$235
OLO
315
DELISTED
Olo Inc
OLO
$538K ﹤0.01%
17,907
+1,062
+6% +$37.9K
PACB icon
316
Pacific Biosciences
PACB
$423M
$508K ﹤0.01%
19,896
-341
-2% -$10.1K
SYBX
317
DELISTED
Synlogic
SYBX
$506K ﹤0.01%
11,061
-76,801
-87% -$3.59M
LNW
318
DELISTED
Light & Wonder
LNW
$451K ﹤0.01%
5,435
-5,411
-50% -$381K
MIMO
319
DELISTED
Airspan Networks Holdings Inc
MIMO
$436K ﹤0.01%
+65,236
New +$586K
VINP icon
320
Vinci Compass Investments Ltd
VINP
$611M
$427K ﹤0.01%
32,786
SILK
321
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$415K ﹤0.01%
7,543
+1,282
+20% +$67.1K
NSTB
322
DELISTED
Northern Star Investment Corp. II
NSTB
$400K ﹤0.01%
+40,297
New +$400K
YETI icon
323
Yeti Holdings
YETI
$2.91B
$392K ﹤0.01%
+4,573
New +$443K
OTLY
324
Oatly Group
OTLY
$407M
$388K ﹤0.01%
1,283
+18
+1% +$6.52K
KTOS icon
325
Kratos Defense & Security Solutions
KTOS
$8.77B
$381K ﹤0.01%
+17,067
New +$422K

Similar funds

Gilder Gagnon Howe & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Gilder Gagnon Howe & Co held 463 positions worth $19.3B, down 5.3% from $20.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co's Q3 2021 filing shows 43 new, 126 increased, 234 reduced and 29 closed positions. Its largest new stake was Duolingo: 1,014,484 shares worth $169M. The largest sale was Watsco Inc, an estimated $99.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q3 2021 buy was Duolingo: 1,014,484 shares worth $169M.
  • Gilder Gagnon Howe & Co added most to Confluent in Q3 2021, an estimated $146M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2021 reduction was Watsco Inc, cutting an estimated $99.3M.
  • Gilder Gagnon Howe & Co fully exited Rodgers Silicon Valley Acquisition Corp. Unit in Q3 2021, selling an estimated $20.7M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2021.
  • Gilder Gagnon Howe & Co opened 43 new positions and closed 29 in Q3 2021.
  • Gilder Gagnon Howe & Co's portfolio value fell 5.3% quarter-over-quarter to $19.3B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2021, filed 15 Nov 2021.